Mylan N.V. recalls Mylan — Nizatidine Capsules 150mg and 300mg
- Recall date
- January 8, 2020
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Mylan N.V., Mylan
Why it was recalled
NDMA (Nitrosodimethylamine) impurity — Unapproved Ingredient
What was recalled
Nizatidine Capsules 150mg and 300mg
Read the official recall notice →
Get recall alerts
Free email alert whenever Mylan N.V. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Mylan N.V., Mylan